Biblio

Author Title [ Type

] Year

Filters: Author is Chiaretti, Sabina [Clear All Filters]

Journal Article

Chiaretti S, Gianfelici V, O'Brien SM, Mullighan CG. Advances in the Genetics and Therapy of Acute Lymphoblastic Leukemia. Am Soc Clin Oncol Educ Book. 2016;35:e314-e322.

Malfona F, Tanasi I, Piccini M, Papayannidis C, Federico V, Mancini V, Roncoroni E, Todisco E, Bianchi S, Ciotti G, et al. BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study. Haematologica. 2023.

Foà R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo M-C, Canichella M, Viero P, Ferrara F, Lunghi M, et al. Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2020;383(17):1613-1623.

Cardinali D, Beldinanzi M, Ansuinelli M, Elia L, Starza IDella, Bellomarino V, Matarazzo M, Di Trani M, Cola M, Salutari P, et al. Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase. Leuk Lymphoma. 2023:1-4.

Candoni A, Lazzarotto D, Ferrara F, Curti A, Lussana F, Papayannidis C, Del Principe MIlaria, Bonifacio M, Mosna F, Delia M, et al. Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory t-cell acute lymphoblastic leukemia/lymphoma. the campus-all study. Am J Hematol. 2020.

Bassan R, Chiaretti S, Starza IDella, Spinelli O, Santoro A, Paoloni FPaola, Messina M, Elia L, De Propris MStefania S, Scattolin AMaria, et al. Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. Blood Adv. 2023.

Malfona F, Testi AMaria, Chiaretti S, Moleti MLuisa. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies. Blood Lymphat Cancer. 2024;14:1-15.